Gabapentin Dosage Calculator

About the Gabapentin Dosage Calculator

Gabapentin (Neurontin) is an anticonvulsant medication widely prescribed for neuropathic pain, postherpetic neuralgia (PHN), and as adjunctive therapy for partial seizures. It is also extensively used off-label for fibromyalgia, restless leg syndrome, anxiety disorders, alcohol withdrawal, and chronic pain syndromes. Gabapentin's unique pharmacokinetics—including saturable absorption that decreases bioavailability at higher doses, exclusive renal elimination, and lack of hepatic metabolism—make precise dosing and titration particularly important.

The recommended approach for starting gabapentin is gradual titration to minimize side effects, particularly somnolence, dizziness, and ataxia. The standard initiation protocol starts with 300 mg on the evening of Day 1, increases to 300 mg twice daily on Day 2, and reaches 300 mg three times daily on Day 3, for a total of 900 mg/day. From there, the dose is increased by 300 mg/day every 1–7 days based on patient response and tolerability, up to a maximum of 3,600 mg/day divided into three doses.

This gabapentin dosage calculator generates individualized titration schedules, applies renal dose adjustments based on creatinine clearance, recommends optimal tablet combinations for each dose step, and displays effective dose ranges for each indication. It accounts for the fact that gabapentin requires significant dose reduction in renal impairment—since it is eliminated entirely by the kidneys—and provides hemodialysis supplemental dosing guidelines.

When This Page Helps

Gabapentin dosing is easy to under- or overshoot because absorption saturates as doses get larger and renal function changes the clearance curve. This calculator lays out the stepwise titration, shows the day-by-day schedule to reach the target, and applies renal limits so the prescribed plan stays within a practical dosing range.

How to Use the Inputs

1. Enter the patient's body weight in kg for dose-per-kg calculations.
2. Select the clinical indication to set the appropriate target dose range.
3. Choose the renal function category based on creatinine clearance.
4. If continuing therapy, enter the current dose and frequency.
5. Optionally specify a target daily dose or use the default for the indication.
6. Set the desired titration timeframe in days.
7. Review the generated titration schedule, tablet combinations, and renal adjustments.

Example Calculation

Tips & Best Practices

• Start low and go slow — 300 mg increments every few days reduces dizziness and sedation.
• Give the largest portion of the daily dose at bedtime to leverage the sedative effect and reduce daytime drowsiness.
• For neuropathic pain, allow 3–8 weeks at target dose before declaring treatment failure.
• Gabapentin absorption is saturable: three 600 mg doses absorb better than two 900 mg doses for the same daily total.
• Space doses approximately 8 hours apart for optimal plasma levels with TID dosing.
• Always taper gabapentin when discontinuing — reduce by no more than 300 mg/day every 3–7 days.

Pharmacokinetics and Absorption

Gabapentin is absorbed in the small intestine via the L-amino acid transporter system, which becomes saturated at higher doses. This means bioavailability decreases from approximately 60% at 300 mg to about 35% at 1,600 mg and further decreases at higher doses. The practical implication is that gabapentin must be given in divided doses (TID) rather than once daily to maximize absorption. The extended-release formulation (gabapentin enacarbil / Horizant) partly addresses this limitation but has different dosing parameters and is not interchangeable with immediate-release gabapentin.

Evidence for Clinical Indications

For postherpetic neuralgia, landmark trials demonstrated that gabapentin at 1,800–3,600 mg/day significantly reduced pain scores versus placebo, with NNT (number needed to treat) of approximately 4–5 for meaningful pain reduction. For partial seizures, gabapentin is effective as adjunctive therapy at 900–3,600 mg/day when added to existing anticonvulsant regimens. Off-label evidence is strongest for diabetic neuropathy, fibromyalgia (though pregabalin has the FDA indication), and perioperative pain management where gabapentin has demonstrated opioid-sparing effects.

Safety and Monitoring

While gabapentin has a relatively benign safety profile, recent concerns include reports of respiratory depression when combined with opioids or in patients with underlying respiratory conditions, abuse potential (gabapentin is now a Schedule V controlled substance in some US states and the UK), and suicidality risk common to all anticonvulsants. Monitor for suicidal ideation, excessive sedation, peripheral edema, and weight gain. Drug levels are not routinely monitored, but can be useful in suspected non-adherence or toxicity.

Frequently Asked Questions

• What is the maximum dose of gabapentin?

  The FDA-approved maximum is 3,600 mg/day divided into three doses for seizure disorders. For neuropathic pain and PHN, effective doses typically range from 1,800 to 3,600 mg/day. Due to saturable absorption, doses above 3,600 mg/day have diminishing returns.

• Why does gabapentin need to be titrated slowly?

  Gradual titration minimizes central nervous system side effects including sedation, dizziness, and ataxia, which are most pronounced when gabapentin is started at full dose. Slow titration also allows the clinician to find the minimum effective dose for each patient.

• How is gabapentin adjusted for kidney disease?

  Gabapentin is eliminated exclusively by the kidneys. CrCl 30–59: reduce to 400–1,400 mg/day BID. CrCl 15–29: 200–700 mg/day QD. CrCl < 15: 100–300 mg QOD. Hemodialysis removes gabapentin significantly, requiring a 125–350 mg supplemental dose after each session.

• Can gabapentin be stopped abruptly?

  No. Abrupt discontinuation of gabapentin can cause withdrawal symptoms including anxiety, insomnia, nausea, pain, and sweating — and may precipitate seizures in patients taking it for epilepsy. Taper by no more than 300 mg/day every 3–7 days.

• Why is gabapentin given three times daily?

  Gabapentin has a relatively short half-life (5–7 hours) and its intestinal absorption is saturable, meaning larger individual doses are absorbed less efficiently. Three-times-daily dosing maintains more consistent plasma levels and maximizes total bioavailable dose.

• What is the difference between gabapentin and pregabalin?

  Pregabalin (Lyrica) has linear pharmacokinetics (no saturable absorption), higher bioavailability (~90% vs. ~60%), and can be dosed twice daily. It is more potent on a mg-for-mg basis. Gabapentin 300 mg TID ≈ pregabalin 75 mg BID roughly in terms of effect.